Actively Recruiting
Treatment of Aerobic Vaginitis in Women Using Baofukang Vaginal Suppository for 7 or 14 Days with Safety and Effectiveness Evaluation
Led by Peking University Shenzhen Hospital · Updated on 2025-06-12
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the treatment of aerobic vaginitis using Baofukang Suppository in two different durations. The study compares the effects of a 7-day treatment group versus a 14-day treatment group to assess both efficacy and safety. Participants are female and diagnosed with aerobic vaginitis based on specific clinical signs including vaginal discharge, elevated pH, and Donders score. Participants receive Baofukang Suppository vaginally at a dose of 1.74 grams, with two capsules administered each night. One group uses the suppository for 7 days, while the other group applies it for 14 days. Both groups are monitored after treatment at intervals of 7 to 14 days and again at 35 to 42 days to evaluate outcomes. During the study, participants will undergo assessments to determine the cure rate at one week and one month after treatment. Safety is also monitored by recording any side effects during the first week following treatment. The study involves random assignment to one of the two treatment groups, and participation includes follow-up visits for outcome evaluations. The total participant age range is from 18 to 55 years.
CONDITIONS
Brief Title
Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository
Research Team
P
Ping Liu, M.D.
Y
Yiheng Liang, M.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here